日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic

使用新型抗体导向纳米治疗剂靶向治疗膀胱癌中的 EphA2

Walid Kamoun, Elden Swindell, Christine Pien, Lia Luus, Jason Cain, Minh Pham, Irawati Kandela, Zhaohua Richard Huang, Suresh K Tipparaju, Alexander Koshkaryev, Vasileios Askoxylakis, Dmitri B Kirpotin, Troy Bloom, Mari Mino-Kenudson, James D Marks, Alena Zalutskaya, Wiam Bshara, Carl Morrison, Dary

Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models

在TAT肽修饰的多功能免疫脂质体中,阿霉素对药物敏感型和耐药型卵巢癌模型均表现出增强的活性。

Apte, Anjali; Koren, Erez; Koshkaryev, Alexander; Torchilin, Vladimir P

Immunoconjugates and long circulating systems: origins, current state of the art and future directions

免疫缀合物和长循环系统:起源、现状及未来方向

Koshkaryev, Alexander; Sawant, Rupa; Deshpande, Madhura; Torchilin, Vladimir

UEG Week 2013 Oral Presentations

2013年UEG周口头报告

Koshkaryev, Alexander; Piroyan, Aleksandr; Torchilin, Vladimir P

Lysosome-targeted octadecyl-rhodamine B-liposomes enhance lysosomal accumulation of glucocerebrosidase in Gaucher's cells in vitro

溶酶体靶向十八烷基罗丹明B脂质体体外增强戈谢氏细胞中葡萄糖脑苷脂酶的溶酶体积累

Ritesh Thekkedath, Alexander Koshkaryev, Vladimir P Torchilin

Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes

转铁蛋白修饰的脂质体中的神经酰胺可增加体外和体内癌细胞的凋亡

Koshkaryev, Alexander; Piroyan, Aleksandr; Torchilin, Vladimir P

Screening and optimization of ligand conjugates for lysosomal targeting

溶酶体靶向配体结合物的筛选和优化

Igor Meerovich, Alexander Koshkaryev, Ritesh Thekkedath, Vladimir P Torchilin

Targeting of lysosomes by liposomes modified with octadecyl-rhodamine B.

利用十八烷基罗丹明B修饰的脂质体靶向溶酶体

Koshkaryev Alexander, Thekkedath Ritesh, Pagano Cinzia, Meerovich Igor, Torchilin Vladimir P